Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolitesResearch in context

Summary: Background: Probiotics have been increasingly proposed for enhancing immune checkpoint blockade (ICB) treatments against cancer. However, its causal relationship with immunotherapeutic efficacy remains unclear, which promoted us to explore if and how probiotic Lacticaseibacillus rhamnosus...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Guangqi Gao, Siyuan Shen, Tao Zhang, Jiachao Zhang, Shi Huang, Zhihong Sun, Heping Zhang
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2023-05-01
Ráidu:	EBioMedicine
Fáttát:	Gut microbiota Anti-PD-1 Probiotics Lacticaseibacillus rhamnosus Probio-M9 α-ketoglutaric acid Synergistic anti-tumor therapeutics
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S2352396423000981
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!